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The 50-ends of two paternally expressed mouse genes, Peg3 and Usp29, are jointly associated with a CpG
island that exhibits allele-specific methylation. Sequence comparison of the regions derived from human,
mouse and cow revealed the presence of two evolutionarily conserved sequence motifs including one that is
repeated multiple times within the first intron of Peg3 in all three mammals. DNA mobility shift and chromatin
immunoprecipitation (ChIP) assays clearly demonstrated that this motif is an in vivo binding site for the
Gli-type transcription factor YY1. The YY1-binding site contains one CpG dinucleotide, and methylation of
this CpG site abolishes the binding activity of YY1 in vitro. The Peg3 YY1-binding sites are methylated only
on the maternal chromosome in vivo, and ChIP assays confirmed that YY1 binds specifically to the paternal
allele of the gene. Promoter, enhancer and insulator assays with deletion constructs of sequence
surrounding the YY1-binding sites indicate that the region functions as a methylation-sensitive insulator
that may influence the imprinted expression of Peg3 and neighboring genes. The current study is the first
report demonstrating the involvement of YY1 in methylation-sensitive insulator activity and suggests a
potential role of this highly conserved protein in mammalian genomic imprinting.
INTRODUCTION
The two parental alleles of certain mammalian genes are
functionally nonequivalent due to genomic imprinting, a
process by which one allele becomes epigenetically modified
and inactivated based on parental origin. More than 50
imprinted genes have been isolated from human and mouse
(www.mgu.har.mrc.ac.uk/imprinting/imprin-ref.html#impregs),
and many of these imprinted genes are involved in either fetal
growth or animal behaviors (1,2). The known imprinted genes
are clustered in discrete chromosomal regions, indicating that
genomic imprinting is a long-range mechanism affecting
relatively large regions of chromosomes (3,4). Several lines
of evidence suggest that small DNA elements may serve to
regulate the imprinting of a whole domain and coordinate the
expression of individual genes in each region (5–7).
The molecular mechanisms that underlie imprinting control
are still elusive but a series of studies focused on the
well-known imprinted domains, including H19/Igf 2, SNRPN
and Igf 2r, have further located the genomic regions that play
critical roles for the imprinting control of each domain (8–10).
Deletions or modifications of these genomic regions, termed
imprinting control regions (ICRs), are shown to affect the
transcription and imprinting of genes locally as well as those
found at relatively distant genomic sites. Common features of
these ICRs include tandem-repeat sequence structures and
close association of, or overlap with, CpG islands that display
allele-specific methylation (11,12). In the case of the H19 ICR,
the sequence of the repeated region is well conserved among
distantly related mammals (13,14). Analyses of the H19 ICR
indicate that the core of these repeated sequences is a binding
site of the transcription factor CTCF, which serves as an
insulator element for the imprinting control of H19 and Igf2.
Peg3 (paternally expressed gene 3) was the first imprinted
gene identified in the proximal imprinted domain of mouse
chromosome 7 (Mmu7) (15), which was predicted originally in
breeding studies with translocation mutant mice (16). Five
additional imprinted genes have been identified subsequently
within the surrounding genomic regions. These include the
paternally expressed genes Usp29 (17) and Zf264 (18), and
maternally expressed genes Zim1 (19), Zim2 (20), and Zim3
(18). Comparative mapping and imprinting studies of this
domain indicate that human homologs of most of the mouse
imprinted genes are located in the syntenically homologous
region of chromosome (HSA19q13.4) (17,21,22), and that
human PEG3 and ZIM2 are also imprinted (23). The clustering
of the imprinted genes in this genomic interval suggests that the
imprinting of this domain may be controlled by a small number
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of ICRs. Sequence comparison of the 500 kb mouse and human
imprinted regions indicate the presence of a number of
evolutionarily conserved genomic fragments (J.Kim et al., in
preparation), including a 5 kb genomic region surrounding the
first exons of Peg3 and Usp29. This conserved region contains
a CpG island that is methylated in an allele-specific pattern in
somatic cells (23,24) as well as in germ cells (25) and includes
an unusual tandem-repeat sequence structure as observed in the
ICRs of other imprinted domains (11). Recent studies have also
shown complete methylation of both parental alleles of this
region in a large fraction of human glioma patients, suggesting
that human PEG3 might function as a tumor suppressor gene
(26,27).
In the current study, we performed a series of functional
studies of this 5 kb conserved, differentially methylated region
(called PEG3-DMR), to investigate potential roles of this
element in the transcription and imprinting control of Peg3 and
Usp29. Three-way sequence comparison analyses of
PEG3-DMR sequences derived from human, mouse and cow
indicate that this region contains at least two evolutionarily
conserved sequence elements, including multiple binding sites
for a Gli-type transcription factor YY1. Our studies show that
the YY1-binding to the motif is methylation-sensitive and that
all of the YY1-binding sites are differentially methylated
between two parental alleles in vivo. Functional assays of this
region suggest that the YY1-binding region acts as a
methylation-sensitive insulator that may play a role in the
imprinting control of this domain.
RESULTS
Identification of two conserved motifs located in the
first intron of Peg3
As shown in other ICRs, the 50-ends of two paternally
expressed genes, Peg3 and Usp29, are also part of a CpG
island exhibiting allele-specific methylation (Fig. 1A). The
sequence structure and evolutionary conservation of this
potential ICR were analyzed by comparing genomic sequences
derived from three distantly related mammals: human, mouse
and cow. To isolate cow BACs containing Peg3, the RPCI-42
library was screened with two probes derived from different
portions of the coding region of mouse Peg3 (described in
Materials and Methods). One of the identified BACs was
selected and sequenced at the Joint Genome Institute
(RPCI42-246L9; GenBank accession no. AC073666).
Examination of the sequence of this bovine BAC indicated
that the overall genomic layout of the Peg3 region is well
conserved in the three mammals (Fig. 1B). In all three species,
three exons are found in the conserved 5 kb interval starting
1 kb upstream of Peg3 and extending to the second exon of that
gene. The region includes Peg3 exons 1 and 2 and an
oppositely oriented transcript that initiates within 150 bp of
Peg3. In mouse, this sequence comprises the first non-coding
exon of the paternally expressed gene, Usp29; the homologous
human region is also included in a non-coding mRNA, called
MIM1 (Mer-repeat containing imprinted transcript 1; Kim et
al., unpublished data), but is not co-transcribed with USP29
(18). The exon structure and imprinting status of the bovine
gene has not yet been determined. The locations and spacing of
these exons are well conserved among the three mammals.
The sequence of the 5 kb genomic region, called
PEG3-DMR, was also examined for evolutionary conservation
and repeated sequence structure. Three-way comparison of
human, mouse and cow sequences identified several conserved
subregions including the three exons and one small genomic
segment, about 40 bp in length, located about 800 bp
downstream of exon 1 (Fig. 2A and B). Owing to the repeated
nature of the Peg3 first intron sequence similarity, searching
and two-way comparative sequence alignment programs, such
as BLAST (www.ncbi.nlm.nih.gov/BLAST/) and PIPMAKER
(http://nog.cse.psu.edu/pipmaker/), did not yield reliable clues
regarding the locations of relevant functional sequences
(Fig. 1B). To perform a more systematic analysis, we used
the ‘printrepeats’ program for identifying and visualizing small
repeat sequences within larger sequence domains. As shown in
Figure 1C and D, the first intron of human, mouse and bovine
Peg3 contains several copies of tandem repeats. Although the
same sequence is reiterated in all three species, the location,
length and number of repeated units vary among the three
mammals. In human and cow, the repeated units are clustered
more compactly with high sequence identity between repeated
units (Fig. 1C and D). By contrast, mouse repeats are more
widely distributed and show relatively high levels of sequence
variation. Sequence similarity of these repeat units is much
higher within any one species than between different species,
suggesting that the repeat units may have been duplicated since
the divergence of rodent, ungulate and primate lineages.
However, comparison of repeat units from different species
clearly demonstrates that the duplicated regions share a
common evolutionary history. Closer examination revealed a
small core region, 11 bp in length, which is highly conserved
both within and between species, whereas surrounding
sequences are more species-specific (Fig. 2C). The 11 bp core
sequence contains one CpG dinucleotide. As expected from the
high mutation rate of CpG dinucleotides to either CpA or TpG
in mammalian genomes (28), many repeat units contain one or
two base changes at the CpG sites (Fig. 2D). Nevertheless, all
three mammals carry 4–6 repeats units with the identical,
canonical sequence. Overall, our analyses of the 5 kb genomic
region identified two highly conserved sequence elements
(CSEs) located in the first intron of Peg3, CSE1 and CSE2
(Fig. 2A).
Multiple binding sites for methylation-sensitive YY1
The two CSEs identified in the first intron of Peg3 represent
strong candidates as regulatory sequences, conserved because
they contain binding sites for unknown transcription factors. To
test this possibility, the two CSEs were first searched against
the Transfac database (http://transfac.gbf.de/TRANSFAC/).
These searches showed that CSE1 contains binding sites for
a number of transcription factors, including Sp1, GCF and
HiNF-C, whereas CSE2 contains sequences corresponding to
the binding site for a Gli-type zinc-finger protein, YY1. To test
the ability of these transcription factors to bind specifically
CSE1 and CSE2 sequences, we performed DNA mobility shift
assays with nuclear extracts prepared from HeLa cells
(Fig. 3A–D). The assays indicated the presence of two
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potential complexes binding to CSE1 in a sequence-specific
manner, with one set of proteins binding to the 30-region and a
second complex binding to the 50-portion of the CSE1
sequence. The identity of the two complexes is currently being
investigated.
To test binding of transcription factor(s) to CSE2, the 32 bp
sequence corresponding to the first repeat unit in the human
sequence was used as a probe for gel shift assays (Fig. 3B–D).
As shown in Fig. 3B, an unknown transcription factor binds to
this CSE2 32mer and the binding is sequence-specific, based
on the selective binding to CSE2 against 100-fold molar excess
of an unrelated probe (in this case CSE1, lane 4 in Fig. 3B).
Since database searches suggested this sequence contained a
YY1 binding site, the binding of this unknown protein from
nuclear extracts was also competed against a commercially
available YY1 consensus oligonucleotide (yy1) probe and a
mutated version (yy2) that has the three nucleotide differences
which are known to disrupt YY1 binding. As shown in Fig. 3B
lanes 5 and 6, only the perfect YY1 consensus probe competed
effectively against the CSE2 probe. To confirm the localization
of YY1 protein within the CSE2-binding complex, we
performed supershift assays with a commercially available
YY1-antibody, which recognizes the zinc-finger portion of
YY1. The supershift assay also included one unrelated
antibody generated against the Usp29 protein, which had been
prepared previously in our laboratory, as a negative control.
The Usp29 antibody did not affect the binding of the complex
to CSE2 but the YY1 antibody inhibited the binding of the
complex to CSE2 significantly (Fig. 3B, lanes 7 and 8). Since
the antigenic epitope of this YY1 antibody corresponds to the
DNA-binding domain, the addition of the YY1 antibody to the
supershift assay is likely to inhibit the binding of YY1 to DNA
rather than shifting the binding complex. To further test this
possibility, we repeated the supershift assays with another
Figure 1. Sequence comparison of the surrounding regions of the first exons of Peg3 and Usp29/MIM1. (A) The genomic organization of six imprinted genes in the
proximal region of Mmu7. Maternally expressed genes are marked in blue whereas names of paternally expressed genes are shown in red. The location and orien-
tation of each transcript are indicated by arrows. The relative position of Peg3-DMR within this imprinted domain is represented by a box below the map. (B) The
8 kb genomic sequences derived from human, mouse and cow Peg3 were analyzed using Pipmaker. The pink-shaded regions correspond to exons and the
yellow-shaded regions to the tandem repeat regions of the first intron of Peg3. The 5 kb DMR region is indicated at the top of the PIP plot. (C–D)
Conservation patterns of tandem repeat sequences located within the first introns of human, mouse and cow Peg3. Inter-species conservation is shown as vertical
lines between upper and lower sequences. Intra-species conservation (tandem repeat sequence) is shown as curved lines to regions within the same sequence.
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Figure 2. Two conserved sequence elements identified from the first intron of Peg3. (A) Positions of two conserved sequence elements (CSEs) within the first
intron of Peg3. The diagram shows the positions and directions of exons within this region. The square indicates CSE1; the circle, CSE2. (B) Sequence alignment
of CSE1s. (C) Sequence alignment of CSE2s. The conserved core and surrounding sequences of human, mouse and cow CSE2s are compared with the consensus
sequence of YY1-binding sites. (D) Sequence alignment of all tandem repeats of human and mouse that show similarity to the consensus sequence of CSE2. Many
tandem repeats of human and mouse show one or two base differences as compared with the core sequence of CSE2.
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Figure 3. DNA mobility shift assays of CSE1 and CSE2. (A) Identification of unknown protein complexes binding to CSE1. (B) Identification of YY1 as a binding
factor for CSE2. Supershift assays were repeated with a second YY1-antibody that is marked with an asterisk (lane 9–12). Lanes 9 and 10 are same as lanes 2 and
3. The antibody used for lanes 7 and 11 recognizes the C-terminal 20 amino acid of YY1 whereas the antibody for lane 12 recognizes the whole protein of YY1.
The shifted position of YY1 by the second antibody is indicated by an arrow. (C) Effect of methylation on YY1-binding. All the probes for this assay were designed
to contain a sequence identical to that of the CSE2 probe, but with or without methylation of the CpG site on one or both strands; u(/) unmethylated, hm(þ/)
methylated on top strand, hm(/þ) methylated on bottom strand, m(þ/þ) methylated on both strands. Lanes 1–4 show results obtained with four different com-
binations of methylated CSE2 sequences as probes without addition of any competitor. Lanes 5–8 shows data obtained unsing unmethylated CSE2 sequences as a
probe and different combinations of methylated CSE2 sequences as competitors. Since this gel image is slanted, lane assignment is shown at both the top and
bottom of the gel image for orientation. (D) The binding specificity of YY1. The CSE2 probe was competed against the two competitors that have single base
changes in the CpG sites. The sequences of each probe used for the analyses are shown at the bottom.
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anti-YY1 antibody, of which the antigenic epitope is the entire
portion of human YY1. As shown in Fig. 3B lane 12, this
antibody shifted the CSE2 probe sequences more significantly
as compared to the first antibody.
Since the consensus-binding site of YY1 contains one CpG
dinucleotide and the YY1 binding sites of Peg3 are part of a
differentially methylated region, we investigated the effect of
methylation on the binding activity of YY1 (Fig. 3C). Despite
several previous attempts by others (29,30), this has never been
tested unambiguously, primarily due to technical difficulties
involved in methylating probes for gel shift assays. To avoid
this problem, the top and bottom strands for the CSE2 duplex
probe were synthesized separately to contain methyl-cytosines.
Four combinations of the CSE2 probe were derived: unmethy-
lated on both top and bottom strands (/), methylated on
both (þ/þ), and methylated on only top (þ/) or bottom
(/þ) strands. As expected, the binding of YY1 was shown
to be very sensitive to methylation. Interestingly, the methyla-
tion effect on the binding of YY1 is strand-specific; the
YY1-binding to DNA is significantly affected only when the
top strand is methylated, suggesting the top strand is the contact
site by YY1. A similar observation has also been observed for
CTCF (14).
As shown in Fig. 2D, the first intron of Peg3 also contains
many potential YY1 binding sites with one or two base
differences compared to the consensus-binding site of YY1. To
test the binding capability of these sites, gel shift assays were
also performed with probes containing a single base difference.
As shown in Fig. 3D, the CpG site is very critical for the
binding of YY1; none of the probes with alternative bases at
this position can serve as effective binding sites. This indicates
that the motifs containing single base differences at the CpG
site do not bind YY1 protein.
In vivo binding of YY1 to CSE2s
To test whether YY1 binds to the CSE2 sequences of human
PEG3 in vivo, chromatin immunoprecipitation (ChIP) assays
were performed with human cells that were grown asynchro-
nously. Cells were treated with formaldehyde to crosslink
protein with DNA, sonicated for DNA fractionation, and
immunoprecipitated with anti-YY1 antibody. As shown in
Fig. 4, the YY1-binding sites of PEG3 (CSE2s) and the
promoter region of the glucocorticoid receptor (GR) gene were
greatly enriched in the anti-YY1 immunoprecipitates. The GR
promoter region contains three YY1 binding sites and
involvement of YY1 in GR expression has been documented
(42); this sequence therefore serves as a positive control for
YY1 binding. In contrast, sequences located immediately
adjacent to the PEG3-DMR YY1-binding sites and from the
30UTR region of PEG3 were not enriched in the immunopre-
cipitated DNA. We also performed ChIP assays to test
YY1-binding to the mouse Peg3 locus using brain tissues
derived from 10-day-old F1 hybrid (M. musculusM. spretus)
mice. Consistent with the human data, sequences containing
the Peg3-DMR YY1-binding sites were enriched in anti-YY1
immunoprecipitates but neighboring Peg3 locus sequences
were not enriched in this pool of DNA.
To determine whether YY1 binds preferentially to one of two
parental alleles, we sequenced the PCR products generated
from immunoprecipitated DNA with the YY1-region primers.
As shown in Fig. 4C, the paternal allele was significantly
enriched in the YY1-immunoprecipitate DNA, confirming that
YY1 binds primarily to the paternal allele of mouse Peg3
in vivo. The above results clearly demonstrated that the CSE2s
located within the first intron of human and mouse PEG3 are
bound by YY1 in vivo in an allele-specific manner.
Methylation status of YY1 binding sites
Since YY1 shows methylation-sensitive binding activity and
the PEG3-DMR is differentially methylated in a parent-of
origin specific manner (23,24), we tested the methylation status
of the actual YY1-binding sites within the mouse region. Since
the four nucleotides of the YY1 binding site (GCGC) are
also recognition sites of the methylation-sensitive enzyme,
HhaI, we employed a strategy similar to that used in other
imprinted regions involving double digestion with one
methylation-sensitive and one non-sensitive restriction enzyme
(Fig. 5A). To detect allele-specific methylation, we used DNAs
derived from interspecific hybrid offspring (F1 and F2) of two
closely related mouse species, M. spretus and M. musculus
(C3H). One BamHI-associated RFLP (restriction fragment
length polymorphism) was detected with a 1.0 kb genomic
DNA probe covering part of the CpG island. Genomic DNA
isolated from F1 hybrid animals was digested with BamHI, and
aliquots were re-digested with HhaI. As shown in Fig. 5A, the
15 kb BamHI fragment of F1 DNA (corresponding to the
M. musculus maternal allele) was resistant to HhaI-digestion
whereas the 10 kb fragment (representing the M. spretus
paternal allele) was effectively digested with HhaI. In the
reciprocal test using F2 offspring, the 15 kb fragment (the
M. musculus paternal allele) was digested but the 10 kb
fragment (the M. spretus maternal allele) was resistant to
Figure 4. ChIP assay of the YY1-binding sites. Asynchronously growing K562 cells were treated with 1% formaldehyde and subject to immunoprecipitation with
anti-YY1 antibodies. Precipitated DNA was PCR-amplified with specific primers. (A) The positions of primer sets used for PCR amplification. Shown are three
primer sets spanning sequences located immediately adjacent to the PEG3-DMRYY1-binding sites. The positions and sequences of the other two remaining primer
sets are described in Materials and Methods. (B) Top panel: testing in vivo YY1-binding for five human target regions. Four of these sequences are derived from the
human PEG3 locus; the promoter region of the human glucocorticoid receptor (GR) gene was included as a positive control. DNA isolated from the sonicated
chromatin, taken before the immunoprecipitation step, was used as ‘input’ DNA whereas DNA samples precipitated with or without anti-YY1 antibodies were
used as ‘anti-YY1’ or ‘’ template DNA, respectively. Bottom panel: testing in vivo YY1-binding of the mouse Peg3 locus. Three Peg3 locus sequences regions
were tested for enrichment in YY1-antibody immunoprecipitated DNA prepared from 10-day-old F1 hybrid mouse brains. (C) Allele determination of the YY1-
immunoprecipitated mouse DNA. The amplified DNA generated with primers surrounding the mouse YY1-binding sites (B), was sequenced and compared with
the M. musculus (maternal) and M. spretus (paternal) parental DNA sequences. Two polymorphic base choices (C or T) that distinguish M. musculus from
M. spretus alleles were detected as a mixed base sequence in PCR products generated from total F1 genomic DNA, but YY1-immunoprecipitated DNA prepared
from the same F1 animal shows only the paternal allele at that position.
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HhaI-digestion. These results indicate specific methylation of
maternal YY1 binding sites. To further demonstrate the
methylation of the YY1 binding sites, three mouse PEG3-
DMR YY1 binding sites were sequenced after bisulfite
treatment, which differentiates methylated cytosine from
unmethylated cytosine (31). The CpG dinucleotide of all three
sites was half-methylated; results from one of these regions are
shown in Fig. 5B. Together these results provide strong
evidence that YY1-binding and the subsequent function of this
protein is allele-specific, with effective YY1 binding occurring
only to the unmethylated paternal allele.
Promoter activity of PEG3-DMR
Because of its overlap with the 50 ends and first exons of the two
mouse genes, PEG3-DMR is likely to harbor promoter elements
for Peg3 and Usp29. Similarly, the human region is expected to
contain elements for regulation of PEG3 and the noncoding
transcript, MIM1. To characterize the promoter activity of this
region, transient reporter assays were performed using a series of
constructs that contained different portions of the human and
mouse PEG3-DMR. Since the two genes are transcribed in
opposite directions, all constructs were tested in both directions.
Because of their close juxtaposition, the region upstream of Peg3
contains the promoter and first exon of Usp29, and vice versa.
All the constructs were tested with 4 different cell lines, two of
human origin (293, PA-1) and two from rodents (Neuro2A,
P19). The promoter assays were repeated at least three different
times in each of the four different cell lines. The results are
summarized in Fig. 6 and Table 1.
In this series of promoter assays, one DNA segment
consistently displayed significant levels of combined promoter
and enhancer activity. Similar constructs were made with
homologous mouse and human sequences and tested in parallel
in all cases summarized below. Constructs containing mouse
and human DNA extending 1 kb upstream from the start site
of Peg3 and oriented so that the Peg3 start site was positioned
nearest the luciferase reporter in the PGL3-basic vector
(construct h2 and m2) showed high levels of promoter activity
in all cell lines. By contrast, the same inserts cloned in the
opposite orientation in the same vector (construct h1 and m1)
did not drive significant luciferase expression in any of the four
cell lines. These results indicate that the 1 kb region contains
the functional Peg3 promoter.
In contrast, significant reporter activity was not detected in
cells transfected with 1 and 4 kb constructs extending from
within the first exon of Usp29/MIM1 into the first intron of
PEG3 (construct set 3–6 in Fig. 6). The 50-ends of Usp29 and
MIM1 have been cloned and sequenced, and lie less than
150 bp from the start of PEG3 in both species (20); it is
therefore highly likely that these DNA segments contain the
promoters for Usp29 and MIM1, respectively. It is unclear
presently why these constructs did not show promoter activity.
Both sets of 1 and 4 kb segments contain sequences within the
PEG3 DMR and it is possible that elements within these
regions may be affecting activity.
A 2 kb segment within the first intron of human PEG3,
surrounding the series of clustered YY1 sites, was also tested
for potential enhancer activity by subcloning into the pGL3-
promoter vector that has the SV40 promoter (data not shown).
The constructs containing the clustered YY1-binding sites did
not show any significant level of enhancer activity in most cell
lines tested.
Insulator activity of the YY1-binding region
The YY1-binding sites of Peg3 and the CTCF-binding sites of
H19 show many similarities, such as localization of multiple
Figure 5. Methylation status of the YY1-binding sites in vivo. (A) Southern blot experiments using genomic DNAs derived from F1 and F2 hybrids of interspecific
crossing of M. musculusM. spretus. The paternal allele (10 kb) of F1 animals was digested with HhaI (methylation-sensitive) while the maternal allele (15 kb)
was resistant to the digestion, indicating methylation on the maternal allele. In the F2 animals, the 10 kb maternal allele is resistant to HhaI digestion. (B) Bisulfite
sequencing of the YY1-binding sites. The electropherogram shows the half-methylation of the second YY1-binding site.
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binding sites within differentially methylated CpG islands
(DMRs) and methylation-sensitive binding activity of the two
transcription factors. We therefore tested whether the
YY1-binding region of Peg3 can function as an insulator
(enhancer-blocking element) as has been shown for the CTCF-
binding sites of H19 DMR. To test this possibility, we used the
assay system that was previously developed to characterize
insulator activity within the chicken globin locus (32,33). This
assay system utilizes a testing vector, pNI-CD, which carries a
neomycin resistance gene (NeoR) reporter under the control of
an erythroid-specific enhancer (32).
To test the YY1-binding region of the PEG3-DMR for
potential insulator activity, genomic fragments spanning
different portions of the human region were subcloned into
the testing vector pNI-CD in both orientations. As a positive
control, the vector construct containing the 250 bp insulator
derived from the chicken globin locus, cHS4, was also included
in our assay (construct 2 in Fig. 7). The insulator activity of
each construct was measured at least three different trials; the
mean values of these measurements with standard errors are
summarized for each construct in Fig. 7. The 2 kb genomic
fragment including the human YY1-binding sites,
hPEG3-YY1, displayed significant levels of insulator activity
in both orientations (constructs 7 and 8), with activity levels
similar to that of the positive control (construct 2, cHS4). The
activity of the construct cloned in one orientation (construct 8)
was slightly higher than that of the same fragment inserted in
the opposite direction (construct 7). To narrow down the
position of active insulator elements within this genomic
interval, two subclones containing different portions of hPEG3-
YY1 were tested individually (Fragments hPEG3-YY1U and
hPEG3-YY1L; constructs 3–6). Both fragments maintained
insulator activity in the pNI-CD vector, but both sub-fragments
showed insulator activity only in one orientation (constructs 4
and 6) and not in the other (constructs 3 and 5). The activity of
hPEG3-YY1U (construct 4) was the highest of all fragments
tested, including the chicken globin locus insulator (construct 2,
cHS4). The orientation dependence of the smaller fragments
remains to be studied further but a similar pattern has been
observed from other insulators, including the insulator located
within the DMR of the Kcnq1 locus (34). These results indicate
that the YY1-binding region may function primarily as an
insulator.
DISCUSSION
We have identified two evolutionarily conserved sequence
elements in the first intron of Peg3, and have demonstrated that
these sequences serve as methylation-sensitive binding sites for
the Gli-type zinc-finger gene, YY1. Our results show that
methylation of the CpG sequence inhibits the binding of YY1
Table 1. Promoter assays (increase relative to pGL3Basic vector)
Construct 293 Neuro2A PA-1 P19
Human h1 — — — —
h2 þþ þþ þþ þþ
h3 þ þ þ þþ
h4 — — þ —
h5 þþ þþ þþ þþ
h6 — — — —
Mouse m1 þ — NA NA
m2 þþþ þþþ NA NA
m3 þ þ þ þ
m4 — — þ þ
m5 þþ þþ þþ þþ
m6 þþ þ þ þ
þþþ, greater than 100-fold; þþ, 100–10-fold; þ , 10–1-fold; —, <1-fold;
NA, not available.
Figure 6. Promoter assays of Peg3-DMR. Several different genomic fragments covering human and mouse Peg3-DMR were subcloned into the pGL3 basic vector
that lacks its own promoter and enhancer. The promoter activities of these constructs were measured and compared with a negative control, the pGL3 basic without
insert. The relative values, indicating the promoter activity of each fragment, are shown in the middle column, and the mouse values are also shown as graphs.
Constructs containing human and mouse genomic DNA fragments are named h1-6 and m1-6, respectively.
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protein to the PEG3-DMR sequence and to consensus binding
sequences in vitro. We have demonstrated that the YY1-binding
sites of PEG3-DMR are methylated in vivo, specifically on the
repressed maternal allele. We have also demonstrated that
effective YY1-binding is restricted to the active, paternal allele
of the PEG3-DMR. The YY1-binding element functions as a
powerful insulator sequence in cell line-based assays. Together
these data suggest that the YY1-binding sequence serves as a
methylation-sensitive insulator for expression control of Peg3
and neighboring genes.
The tandemly repeated YY1 binding motifs within the
PEG3-DMR are highly conserved within species but compari-
son of human, mouse and cow repeats reveals a high degree of
interspecies divergence outside the highly conserved 11 bp
YY1-binding core sequence. These data suggest the indepen-
dent duplication and continuous homogenization of these
repeat units since the divergence of mammalian lineages.
Human, mouse and cow each carry more than 10 copies of the
repeat unit within the 5 kb PEG3-DMR, including four to six
copies with functional binding sites for YY1. Similar types of
tandem repeat structures have been observed within DMRs in
several other imprinted domains (11,12). Given the unstable
nature of such sequence structures in mammalian genomes,
their maintenance suggests that the repeats serve an important
function. It has been postulated that the repeated sequences
may play a role in establishment or maintenance of genomic
imprinting, for example by attracting site-specific methylation
(11,12). In the case of the PEG3-DMR, it appears that
continuous duplication of the short sequence repeats may have
served as a mode for maintaining multiple, active copies of the
YY1-binding sequence within the PEG3-DMR despite instabi-
lity and sequence drift during mammalian evolution.
What function does YY1 serve in the Peg3 region and why
are multiple copies of YY1-binding sites required? Results
presented here suggest that the YY1-binding region can
function as an insulator element. Although these data do not
rule out the possibility that the YY1-binding element might
also function as a cell type-specific enhancer, none of the
enhancers described to date comprise tandem arrays of binding
sites for a single transcription factor. In contrast, all of the
known invertebrate and vertebrate insulators contain tandem
arrays of sites similar to those observed within the
PEG3-DMR. Examples include the gypsy and scs/scs’
insulators of Drosophila that contain multiple binding sites
Figure 7. Insulator assay of the YY1-binding region. Several genomic fragments covering different parts of the YY1-binding region within human PEG3-DMR
were subcloned into the pNI-CD vector to test insulator activity. The orientation and coverage of the fragments are shown as arrows. The testing fragments were
located between an erythroid-specific enhancer (E) and a chicken insulator (cHS4) identified from chicken b-globin locus. The average values, with standard errors,
are shown in the middle column and presented as graphs.
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for SU(HW) and BEAF-32, respectively, and Repeat Organizer
of Xenopus rRNA genes and the ICR of mammalian H19
which contain multiple binding sites for CTCF (35). The actual
mechanisms are still under study but it is thought that binding
of multiple transcription factors might be necessary to induce
changes in local chromatin structures that are required for
insulator activity (36). Based on these observations, we
hypothesize that the YY1-binding region of the PEG3-DMR
functions as an insulator influencing expression control of Peg3
and neighboring imprinted genes.
Since YY1 was initially identified as a binding factor to the
LTR region of IAP elements, it has been shown to be involved
in the transcriptional control of a large number of viral and
cellular genes (37). YY1 functions as a repressor, activator, or
transcriptional initiator, depending upon the sequence context
of binding sites with respect to other regulatory elements. The
Drosophila YY1 homolog has been identified as a
DNA-binding factor for the Polycomb genes, which are
involved in heritable silencing mechanisms (38). The vertebrate
YY1 protein has also been shown to interact with a member of
the Polycomb group (Pc-G) of genes, EED (embryonic
ectoderm development) (39,40), suggesting that YY1 also
plays a role in vertebrate gene silencing mechanisms. Results
presented here add another potential dimension to the
functional versatility of this highly conserved Gli-type zinc-
finger protein factor, by implicating YY1 in methylation-
sensitive insulator activity and control of imprinted gene
expression.
Based on the shared features of this region with other ICRs, we
predict that the PEG3-DMR plays a significant role in control of
imprinted expression. It is interesting to note that in mouse a
maternally expressed gene, Zim1, lies directly downstream of
Peg3 and the YY1-binding domain is positioned between
paternally expressed and maternally expressed promoters
(Fig. 1A). Although there are some similarities between PEG3-
DMR and H19 ICR, understanding the potential function of the
PEG3-DMR in regulating imprinted expression of neighboring
genes will require further studies. The PEG3-DMR may also
serve functions that are not directly related to regulating
expression of imprinted genes. The borders of this imprinted
domain are filled with clustered gene families, including an
MKR5-like zinc-finger gene cluster in HSA19 and the OLFR5
cluster of olfactory receptor genes in mouse (41) (www.ensembl.
org/). Consistent with the function of insulator sequences within
the b-globin gene cluster (33,35), the PEG3-DMR might
alternatively act as a ‘boundary’ element that shields these gene
clusters from the influence of elements involved in establishing
the chromatin structures and allele-specific methylation asso-
ciated with imprinting control. The present study sets the stage for
informed design of targeted mutations in mice, to delineate the
precise functional role of allele-specific YY1 binding in
regulation of this conserved imprinted domain.
MATERIALS AND METHODS
Cow BAC isolation and sequence analyses
Two different DNA fragments corresponding to the coding
region of mouse Peg3 (GenBank accession no. AB003040,
181–401 and 4705–5080, respectively) were used for screening
the cow BAC libraries (RPCI42; CHORI, Oakland, CA, USA).
Four identified BACs (RPCI42-91A11, 246L9, 184C9, 194K5)
were further analyzed with pulse-field-gel electrophoresis and
subsequent Southern blot experiments to check the integrity of
identified BACs. One of these BACs, 246L9, was submitted for
sequencing to the Joint Genome Institute of DOE (Walnut
Creek, CA, USA). The 8 kb genomic sequences surrounding
the first exon of Peg3 from human, mouse and cow (GenBank
accession no. AC006115, AC020961, AC073666) were
initially analyzed using 2Blast (www.ncbi.nlm.nih.gov/
BLAST/), VISTA (www.gsd.lbl.gov/vista/), and PIP plot
(http://nog.cse.psu.edu/pipmaker/). Later, the three sequences
were further analyzed using the printrepeat program of the
UNIX computer to visualize tandem-repeat sequence structures
of the first intron of Peg3.
DNA mobility shift assays
Gel Shift Assay systems (Promega, Madison, WI, USA) were
used for all our DNA mobility shift assays. In brief, about 4 mg
of nuclear extracts were first mixed with binding buffer
and unlabeled competitor probes with varying amounts
(10–100 pmol) for 20 min at room temperature and later mixed
with the P32-labeled duplex probes (1 pmol) for an additional
10 min at room temperature. The reaction mixtures were
separated on 5% native polyacrylamide gel (acryl : bis¼
37.5 : 1) in 0.5 Tris buffer at pH 8.0 for 2 h, and the separated
gels were exposed to X-ray films for 1 h. For supershift assays,
two polyclonal antibodies raised against the C-terminal and
entire regions of human YY1, respectively, were obtained from a
commercial firm (SantaCruz Biochem, Santa Cruz, CA, USA)
and the antibody against human Usp29 was prepared by another
commercial firm (SynPep, Dublin, CA, USA). All the gel shift
assays used nuclear extracts prepared from human HeLa cell
lines (Promega, Madison, WI, USA).

















AGCG-30). The methylated oligonucleotides for CSE2 were
prepared using methyl-cytosines (NEB, Beverly, MA, USA).
Chromatin immunoprecipitation assay
Asynchronously grown K562 cells were used for our ChIP
assays to test the YY1-binding on the human PEG3 locus.
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ChIP assays were performed according to the protocol provided
by Upstate Biotechnology (Upstate Biotech, Lake Placid, NY,
USA) with minimal modifications. Briefly, formaldehyde was
added into the K562 cells (1.0 107) at the final concentration
of 1% and incubated at 37C for 10 min. The treated cells were
sonicated for DNA fractionation and further precipitated with
anti-YY1 antibodies (SantaCruz Biochem, Santa Cruz, CA,
USA). The precipitated DNAs were used as template DNAs for
PCR amplification with the following primer sets: PEG3-
promoter (50-CAGCCCAGGGTGGACATCTC-30, 50-CAGCC
TTCGCGCCAAACTGTT-30), PEG3-YY1 sites (50-CAAGGA
GCGCGGCACTCCAC-30, 50-GGCAGATGCGGCGGGGCA
AG-30), PEG3-2nd exon (50-TGACACTTTCCTACTGCAT
ATG-30, 50-CCACAGCTTTAATTCCCAAATAG-30), PEG3-
30UTR (50-ACCAACTCAATATGTGTTTG-30, 50-GATGAA
AGGTTATTAGCCTG-30), and GR-promoter (50-CCCCCT
GCTCTGACATCTT-30, 50-CTTTTCCGAGGTGGCGAGTA
TC-30). PCR amplifications were carried out for 33 cycles
using standard PCR conditions.
To test in vivo YY1 binding at the mouse Peg3 locus, brain
tissue from 10-day-old F1 hybrid animals were used for ChIP
assays. One gram of tissue was homogenized in 10 ml of PBS
buffer and treated with 1% formaldehyde for 15 min at 37C.
The following steps for ChIP assays were same as the ChIP
experiments of the human PEG3 locus. The primer sets used




and Peg3-30UTR (50-CTTCTGGAAGCCGACATTAT-30, 50-
CCTGATCAATGGGTTCCTTG-30). Both human and mouse
ChIP assays were repeated at least three different times.
Methylation studies of the YY1-binding sites
The methylation status of the YY1-binding sites was analyzed
using genomic DNAs derived from the F1 and F2 hybrid
offspring of the cross of C3H (M. musculus) and M. spretus.
About 10 mg of DNAs were first digested with BamHI for 12 h
and later digested with methylation-sensitive HhaI for an
additional 4 h. The digest DNAs were separated on 0.8%
agarose gel electrophoresis, blotted onto nylon membranes,
hybridized with one P32-labeled probe derived from the 1 kb
genomic region surrounding the first exon of mouse Peg3
(GenBank accession no. AC020961, 106127-107242). For
bisulfite sequencing of the YY1-binding site, we followed an
established protocol (31) with minimum modifications. In brief,
mouse genomic DNAs (4 mg) was first digested with EcoRI for
16 h, denatured with 0.3 M NaOH for 30 min. The prepared
DNAs were treated with sodium bisulfite for 16 h at 55C. After
all the chemical treatments, the DNAs were washed with the
Wizard DNA clean-up system (Promega, Madison, WI, USA)
and dissolved with 50 ml of TE for storage. One microliter of the
treated DNA was used as a template for the PCR amplification.
The three YY1-binding sites of mouse Peg3 were amplified and
analyzed for sequencing. For the amplification of the YY1-
binding sites, nested PCRs for each YY1-binding site were
performed at the annealing temperature ranging from 45 to
50C. The oligonucleotide sequences for the YY1-binding site
presented in Fig. 4B are as follows; the first round
(50-GGTGTTATTATGAGTGATAGTTTAG-30, 50-TCAATCA
AAACCTAAACCCCACCCTC-30) and the second round
(50-TTTAGATGGTTGTAGGAGGTGGGTT-30, 50-CCTCAA
ACCCACCCCCTAAAACCAA-30). To monitor the efficiency
of the bisulfite treatment, the PCR products were subcloned into
the TA cloning vector and 10 different clones were sequenced
individually. If more than 90% of cytosine was converted into
thymidine, those DNA samples were selected for our bisulfite
sequencing analyses. Our analyses on the three YY1-binding
sites were repeated at least three different times. The sequence
information regarding oligonucleotides for the other two YY1-
binding sites is available upon request from the authors.
Promoter and enhancer assays
DNA fragments of interest were generated by PCR for
subsequent cloning into the pGL3basic and pGL3promoter
vectors (Promega, Madison, WI, USA). Each fragment was
cloned in both orientations. We list here the locations of the
oligonucleotides used for subcloning experiments. Human
DNA fragments were derived from BAC CIT-B-470F8
(GenBank accession no. AC006115): clone h1 and h2
(163502/164513), h3 and h4 (163794/162832), h5 and h6
(163794/161700). Mouse DNA fragments were from BAC
RG-MBAC247N19 (GenBank accession no. AC020961):
clone m1 and m2 (106891/107836), m3 and m4 (107242/
106127), m5 and m6 (107242/103099). All cell lines were
co-transfected with the construct of interest and pTK-Renilla as
an internal control, using Lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA, USA) as per the manufacturer’s
instruction. Twenty-four hours post transfection, cells were
analyzed for luciferase activity using Dual-Luciferase Assay
system (Promega, Madison, WI, USA) as per the manufac-
turer’s instruction. Plates were read in triplicate by a
LumiCount plate reader (Packard, Meriden, CT, USA).
Experiments were performed in 96-well plates in duplicate
and each experiment was performed more than three times.
Insulator assays
DNA fragments of interest were cloned into the AscI site of
pNI-CD (generous gift from Dr Gary Felsenfeld and Dr Adam
West). Each fragment was cloned in both orientations. The
locations of the tested DNA fragments within human
BAC CIT-B-470F8 (GenBank accession no. AC006115) are
hPEG3-YY1U (161973/161189) and hPEG3-YY1L (161209/
160414). Constructs were transfected into K562 cells by
electroporation at 200 V, 1000 mF (double pulse) using a
Bio-Rad Gene Pulser II. After a 10 min recovery on ice, cells
were plated into RPMI supplemented with 10% FBS, 200 mM
L-glut and Pen/Strep. Twenty-four hours post transfection, cells
were washed and resuspended in Improved MEM zinc option
(GibcoBRL, Rockville, MD, USA). Cells were plated into
0.3% soft agar with 1050 mg/ml Geneticin (GibcoBRL,
Rockville, MD, USA) and incubated at 37C for 18–21 days.
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